EGFR and breast cancer: Together, the increase in drug-induced apoptosis and the corresponding decrease in the CTI caused by IAP inhibition in BT474 and MDAMB468 cells demonstrate that IAPs can mediate resistance to ErbB antagonist-induced apoptosis in breast cancer cell lines.